Affordable Access

deepdyve-link
Publisher Website

Development of a new Aerosol Barrier Mask for mitigation of spread of SARS-CoV-2 and other infectious pathogens

Authors
  • Karam, Karam Abi1
  • Hota, Piyush1, 2
  • Mora, S. Jimena1
  • Lowell, Amelia3
  • McKay, Kelly3
  • Xian, Xiaojun1
  • Patel, Bhavesh3
  • Forzani, Erica1, 2
  • 1 Center for Bioelectronics and Biosensors, Biodesign Institute, Arizona State University, Tempe, 85281, Arizona, USA
  • 2 School of Engineering for Matter, Transport, and Energy, Arizona State University, Tempe, 85281, Arizona, USA
  • 3 Mayo Clinic, Phoenix, 85054, Arizona, USA
Type
Published Article
Journal
medRxiv
Publisher
Cold Spring Harbor Laboratory
Publication Date
Feb 12, 2021
Identifiers
DOI: 10.1101/2021.02.11.21251593
PMID: 33594375
PMCID: PMC7885934
Source
PubMed Central
Keywords
Disciplines
  • Article
License
Unknown

Abstract

The COVID-19 pandemic has caused huge impact on public health and significantly changed our lifestyle. This is due to the fast airborne oro-nasal transmission of SARS-CoV-2 from the infected individuals. The generation of liquid aerosolized particles occurs when the COVID-19 patients speak, sing, cough, sneeze, or simply breathe. We have developed a novel aerosol barrier mask (ABM) to mitigate the spread of SARS-CoV-2 and other infectious pathogens. This Aerosol Barrier Mask is designed for preventing SARS-CoV-2 transmission while transporting patients within hospital facilities. This mask can constrain aerosol and droplet particles and trap them in a biofilter, while the patient is normally breathing and administrated with medical oxygen. The system can be characterized as an oxygen delivery and mitigation mask which has no unfiltered exhaled air dispersion. The mask helps to prevent the spread of SARS-CoV-2, and potentially other infectious respiratory pathogens and protects everyone in general, especially healthcare professionals.

Report this publication

Statistics

Seen <100 times